Literature DB >> 21039631

Increased ethanol consumption and preference in mice lacking neurotensin receptor type 2.

Moonnoh R Lee1, David J Hinton, Sencan S Unal, Elliott Richelson, Doo-Sup Choi.   

Abstract

BACKGROUND: Neurotensin receptors (NTS) regulate a variety of the biological functions of neurotensin (NT) in the central nervous system. Although NT and neurotensin receptors type 1 (NTS1) are implicated in some of the behavioral effects of ethanol, the functional roles of neurotensin receptors type 2 (NTS2) in ethanol intoxication and consumption remain unknown. Here, we investigated behavioral effects mediated by NTS2 in response to ethanol, which are implicated in ethanol consumption and preference, using NTS2 null mice.
METHOD: First, we examined ethanol-induced locomotion, ataxia, hypnosis, and hypothermia in NTS2 null mice. Next, we measured ethanol consumption and preference in NTS2 null mice by giving them free choice between ethanol- and tap water-containing bottles. Then using a brain-permeable NT analog, NT69L, we examined the role of NTS2 in locomotor activity and ataxia. Finally, we examined the effect of NT69L on ethanol consumption and preference in NTS2 null mice.
RESULTS: We found that NTS2 null mice appear less sensitive to the acute hypnotic effects of ethanol and consumed more ethanol compared to wild-type littermates in a 2-bottle choice experiment, even though ethanol-induced locomotion, ataxia, and hypothermia were similar between genotypes. Interestingly, the administration of NT69L for 4 consecutive days significantly reduced alcohol consumption and preference in wild-type littermates as well as in NTS2 null mice.
CONCLUSIONS: Our findings suggest that NTS2 regulates ethanol-induced hypnosis and ethanol consumption.
Copyright © 2010 by the Research Society on Alcoholism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21039631      PMCID: PMC3058519          DOI: 10.1111/j.1530-0277.2010.01326.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  57 in total

1.  Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia.

Authors:  Anne Remaury; Natalio Vita; Sylvain Gendreau; Mireille Jung; Michelle Arnone; Martine Poncelet; Jean-Michel Culouscou; Gérard Le Fur; Philippe Soubrié; Daniel Caput; David Shire; Manfred Kopf; Pascual Ferrara
Journal:  Brain Res       Date:  2002-10-25       Impact factor: 3.252

2.  Immunohistochemical distribution of NTS2 neurotensin receptors in the rat central nervous system.

Authors:  Philippe Sarret; Amélie Perron; Thomas Stroh; Alain Beaudet
Journal:  J Comp Neurol       Date:  2003-07-07       Impact factor: 3.215

3.  The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami.

Authors:  R Carraway; S E Leeman
Journal:  J Biol Chem       Date:  1973-10-10       Impact factor: 5.157

4.  Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice.

Authors:  Yanqi Liang; Mona Boules; Zhimin Li; Katrina Williams; Tomofumi Miura; Alfredo Oliveros; Elliott Richelson
Journal:  Neuropharmacology       Date:  2010-03-06       Impact factor: 5.250

5.  The type 1 equilibrative nucleoside transporter regulates anxiety-like behavior in mice.

Authors:  J Chen; L Rinaldo; S-J Lim; H Young; R O Messing; D-S Choi
Journal:  Genes Brain Behav       Date:  2007-03-21       Impact factor: 3.449

6.  Effect of amphetamine on extracellular concentrations of amino acids in striatum in neurotensin subtype 1 and 2 receptor null mice: a possible interaction between neurotensin receptors and amino acid systems for study of schizophrenia.

Authors:  Zhimin Li; Yanqi Liang; Mona Boules; Andres Gordillo; Elliott Richelson
Journal:  Neuropharmacology       Date:  2010-03-01       Impact factor: 5.250

7.  Neurotensin receptor type 1 regulates ethanol intoxication and consumption in mice.

Authors:  Moonnoh R Lee; David J Hinton; Jane Y Song; Kyung Won Lee; Christopher Choo; Heidi Johng; Sencan S Unal; Elliott Richelson; Doo-Sup Choi
Journal:  Pharmacol Biochem Behav       Date:  2010-02-01       Impact factor: 3.533

8.  The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference.

Authors:  Doo-Sup Choi; Maria-Grazia Cascini; William Mailliard; Hannah Young; Peter Paredes; Thomas McMahon; Ivan Diamond; Antonello Bonci; Robert O Messing
Journal:  Nat Neurosci       Date:  2004-07-18       Impact factor: 24.884

9.  Comparison of mice deficient in the high- or low-affinity neurotensin receptors, Ntsr1 or Ntsr2, reveals a novel function for Ntsr2 in thermal nociception.

Authors:  Hiroshi Maeno; Kazuyuki Yamada; Yuko Santo-Yamada; Kumiko Aoki; Ying-Jie Sun; Eiichi Sato; Tatsuo Fukushima; Hiroo Ogura; Tsutomu Araki; Sari Kamichi; Ichiro Kimura; Mariko Yamano; Yuka Maeno-Hikichi; Kei Watase; Shunsuke Aoki; Hiroshi Kiyama; Etsuko Wada; Keiji Wada
Journal:  Brain Res       Date:  2004-02-13       Impact factor: 3.252

10.  Distribution of NTS3 receptor/sortilin mRNA and protein in the rat central nervous system.

Authors:  Philippe Sarret; Pascale Krzywkowski; Laura Segal; Morten S Nielsen; Claus M Petersen; Jean Mazella; Thomas Stroh; Alain Beaudet
Journal:  J Comp Neurol       Date:  2003-07-07       Impact factor: 3.215

View more
  15 in total

Review 1.  Genes and Alcohol Consumption: Studies with Mutant Mice.

Authors:  J Mayfield; M A Arends; R A Harris; Y A Blednov
Journal:  Int Rev Neurobiol       Date:  2016       Impact factor: 3.230

2.  Heightened Exploratory Behavior Following Chronic Excessive Ethanol Drinking: Mediation by Neurotensin Receptor Type 2 in the Anterior Paraventricular Thalamus.

Authors:  Surya Pandey; Jessica R Barson
Journal:  Alcohol Clin Exp Res       Date:  2020-07-26       Impact factor: 3.455

3.  Behavioral and Neurobiological Consequences of Hedonic Feeding on Alcohol Drinking.

Authors:  Julianna Brutman; Jon F Davis; Sunil Sirohi
Journal:  Curr Pharm Des       Date:  2020       Impact factor: 3.116

4.  Neurotensin in the posterior thalamic paraventricular nucleus: inhibitor of pharmacologically relevant ethanol drinking.

Authors:  Surya Pandey; Preeti S Badve; Genevieve R Curtis; Sarah F Leibowitz; Jessica R Barson
Journal:  Addict Biol       Date:  2017-09-06       Impact factor: 4.280

5.  Chronic caffeine exposure in adolescence promotes diurnal, biphasic mood-cycling and enhanced motivation for reward in adult mice.

Authors:  David J Hinton; Lindsey G Andres-Beck; Kelle E Nett; Alfredo Oliveros; Sun Choi; Marin Veldic; Doo-Sup Choi
Journal:  Behav Brain Res       Date:  2019-05-13       Impact factor: 3.332

6.  Levo-tetrahydropalmatine decreases ethanol drinking and antagonizes dopamine D2 receptor-mediated signaling in the mouse dorsal striatum.

Authors:  Taehyun Kim; David J Hinton; Sandy Johng; Jia Bei Wang; Doo-Sup Choi
Journal:  Behav Brain Res       Date:  2013-01-31       Impact factor: 3.332

7.  Manipulations of Central Amygdala Neurotensin Neurons Alter the Consumption of Ethanol and Sweet Fluids in Mice.

Authors:  María Luisa Torruella-Suárez; Jessica R Vandenberg; Elizabeth S Cogan; Gregory J Tipton; Adonay Teklezghi; Kedar Dange; Gunjan K Patel; Jenna A McHenry; J Andrew Hardaway; Pranish A Kantak; Nicole A Crowley; Jeffrey F DiBerto; Sara P Faccidomo; Clyde W Hodge; Garret D Stuber; Zoé A McElligott
Journal:  J Neurosci       Date:  2019-11-19       Impact factor: 6.167

8.  Selection for drinking in the dark alters brain gene coexpression networks.

Authors:  Ovidiu D Iancu; Denesa Oberbeck; Priscila Darakjian; Pamela Metten; Shannon McWeeney; John C Crabbe; Robert Hitzemann
Journal:  Alcohol Clin Exp Res       Date:  2013-03-29       Impact factor: 3.455

Review 9.  Circuit and neuropeptide mechanisms of the paraventricular thalamus across stages of alcohol and drug use.

Authors:  Matthew C Hartmann; Kristen E Pleil
Journal:  Neuropharmacology       Date:  2021-08-11       Impact factor: 5.273

10.  Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy.

Authors:  Zherui Wu; Daniel Martinez-Fong; Jean Trédaniel; Patricia Forgez
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-17       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.